Skip to main content
Skip to section navigation
Skip to footer
About ViraxImmune
TM
Our Team
Board Members
Media
Contact Us
Products
Investor Relations
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity Matrix
All SEC Filings
Filing Type:
View All
20-F
424B3
424B4
424B5
6-K
8-A12B
CERT
CORRESP
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-3
FWP
NT 20-F
SC 13G
UPLOAD
Year:
View All
2024
2023
2022
2021
Date
Form
Description
PDF
XBRL
Pages
06/11/24
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
4
04/25/24
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-99.1
6
04/16/24
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-99.1
6
03/15/24
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-99.1
7
02/14/24
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
7
01/22/24
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-5.1
EX-10.1
54
01/22/24
424B5
Prospectus filed pursuant to Rule 424(b)(5)
60
01/12/24
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-99.1
EX-99.2
35
12/21/23
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Documents
expand_more
EX-99.1
7
12/20/23
424B3
Prospectus filed pursuant to Rule 424(b)(3)
4
rss_feed
Filing RSS
Page
1
Page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Page
10
Next Page
arrow_forward
Email Alerts
Contacts
RSS News Feed